NGS research for COVID-19

We have partnered with customers to offer new targeted NGS products to meet the urgent demand for COVID-19 research. Amplicon sequencing and hybridization capture can provide genomic insight to SARS-CoV-2 for research related to detection, characterization, and analysis of the virus. Several options for sequencing are currently available:

  • Primer set (provided via collaboration with the ARTIC network)
  • rhAmpSeq™ Amplicon Sequencing Panel
  • xGen™ hybridization capture sequencing

These NGS tools are ready to ship, and our team is standing by to assist you with any questions.